Tezepelumab for Nasal Polyps in Chinese Adults
Treatments studied
Part of Ear, nose & throat clinical trials.
This study tests whether tezepelumab, a new injectable medicine, can help reduce nasal polyps and improve symptoms like nasal congestion, loss of smell, and sleep problems. You would receive the study drug while continuing your current nasal steroid spray, and your doctors would track how your symptoms change.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and weigh at least 40 kg (about 88 lbs)
- You must have been diagnosed with nasal polyps for at least 12 months and have moderate-to-severe symptoms despite current treatment
- You must have tried or been unable to use standard nasal steroid treatment, and either had sinus surgery before or taken oral/injectable steroids for polyp flare-ups in the past year
- You cannot have certain lung diseases, active infections, or uncontrolled health conditions that could affect the study results
- If you are a woman who can become pregnant, you must use reliable birth control during the study and for 16 weeks after your last injection
- You cannot take certain other biologic medicines, immunosuppressive drugs, or live vaccines during the study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well tezepelumab works for people with chronic sinusitis and nasal polyps. It tracks symptoms and quality of life in real-world settings in Japan. If you have this condition and are considering tezepelumab, this study may help doctors understand its benefits.
This trial tests a medication called tezepelumab to see if it can improve symptoms for people with chronic sinusitis and nasal polyps who also have severe asthma. It may help reduce inflammation and improve breathing and nasal symptoms.
This study tests whether combining mepolizumab (a biologic injection) with a quick in-office removal of nasal polyps improves symptoms better than usual care. It is for adults with chronic sinusitis and nasal polyps who qualify for biologic therapy.
This study tests a new medication called CM326 for people with long-term sinus inflammation and nasal polyps. The goal is to see if it reduces symptoms like congestion and improves quality of life. You will receive either the study drug or a placebo.
This trial tests a new injection (SHR-1905) for people with chronic sinusitis and nasal polyps who still have symptoms despite using standard nasal spray treatments. It aims to see if the drug can reduce polyp size and improve symptoms.
This study tests whether dupilumab, a medication given as an injection, helps improve the lining of the nose in people with chronic sinus inflammation and nasal polyps. If you have nasal polyps and are about to start dupilumab, or if you have sinusitis without polyps, you may be eligible to join.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.